Clinical Trial: Prevalence, Risk Factors and Consequences Related to Cesarean Scar Defect (Defect in Cesarean Scar)

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational [Patient Registry]

Official Title: Defect in Cesarean Scar: A Prospective Study of Prevalence, Risk Factors and Impact on Menstrual Disorders and Quality of Life

Brief Summary:

The rates of cesarean section (CS) are rising all over the world. Worldwide the number of CS is millions every year. CS is one of the most frequently performed operation for women. As a consequence many women have a scar in their uterus. Cesarean scar may be associated with complications in later pregnancies. In recent years there have also been a few reports indicating that cesarean scar could potentially be associated with menstrual disorders and infertility. The impact of cesarean scar defect on long term welfare or quality of life is not clear.

In some women with a history of CS it is possible to recognise a defect in the site of previous uterotomy years after the performed CS by sonographic examination. This defect in the scar, also called as a niche, is a consequence of incomplete healing of the scar in the lower part of uterus. To date there is uncertainty relating to the factors that lead to poor healing of cesarean scar. Also impact of cesarean scar defect on later well-being and later pregnancies are not properly known.

The purpose of this study is to investigate the prevalence and the risk factors of cesarean scar defect. Also the impact of cesarean scar defect on women´s menstrual health, fertility, further deliveries and quality of life will be investigated.

This study is a prospective observational cohort study. Women at the age of 18-45 years who will give birth by elective or emergency CS will be asked to participate. Women are recruited within two days of CS. Women with known uterus anomaly or von Willebrand disease will be excluded.

The prevalence of scar defect will be evaluated by transvaginal sonography and contrast-enhanced sonohysterography using saline infusion. Both 2-dimensional and 3-dimension

Detailed Summary:
Sponsor: Tampere University Hospital

Current Primary Outcome: Association between cesarean scar defect and post menstrual spotting [ Time Frame: 15 months ]

Postmenstrual spotting is defined as ≥2 days of brownish discharge at the end of menstrual bleeding with total bleeding days ≥7 or inter menstrual non-cyclic bleeding not related to menstruation.


Original Primary Outcome: Same as current

Current Secondary Outcome:

  • Quality of life related to cesarean scar defect [ Time Frame: 10 years ]
    Quality of life related to cesarean scar defect will be assessed by using rand36 score.
  • Association between cesarean scar and adverse pregnancy outcome [ Time Frame: 10 years ]
    Adverse pregnancy outcome includes spontaneous abortion, cesarean scar pregnancy, uterine rupture in later pregnancy and the rate of vaginal birth/cesarean section in later pregnancies.
  • Prevalence of cesarean scar defect measured by sonography [ Time Frame: 6 months ]
    Number of participants with cesarean scar defect. Cesarean scar defect is defined as myometrial discontinuity with a depth of ≥2 mm at the site of cesarean scar that communicates with the uterine or cervical cavity as seen on transvaginal sonography with or without saline infusion.
  • Impact of cervical opening at the time of cesarean section on the prevalence of cesarean scar defect. [ Time Frame: 6 months ]
    Association between cervical opening at the time of operation (cm) and detected cesarean scar defect (6 months after the operation).


Original Secondary Outcome: Same as current

Information By: Tampere University Hospital

Dates:
Date Received: March 9, 2016
Date Started: January 2016
Date Completion: April 2027
Last Updated: October 17, 2016
Last Verified: October 2016